Susquehanna International »

Sionna Therapeutics shares owned by Susquehanna International

Quarter-by-quarter ownership of Sionna Therapeutics (SION) shares owned by Susquehanna International from 13F filings

Historical chart of Susquehanna International investment in Sionna Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Sionna Therapeutics held by Susquehanna International consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sionna Therapeutics by Susquehanna International

Quarter filed Position value Share count Share price at filing
2026-03-31 $293k 7.3k 40.09
2025-06-30 $257k 15k 17.35

More positions owned by Susquehanna International

State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
NVIDIA Corporation (NVDA)
Tesla Motors (TSLA)
Microsoft Corporation (MSFT)
Spdr Gold Tr Gold Shs (GLD)
Meta Platforms Cl A (META)
Apple (AAPL)
Ishares Tr Russell 2000 Etf (IWM)
Micron Technology (MU)
Taiwan Semiconductor Manufac Sponsored Ads (TSM)
Alphabet Cap Stk Cl A (GOOGL)
Amazon (AMZN)
Advanced Micro Devices (AMD)
Netflix (NFLX)

View all positions for Susquehanna International

Top funds holding Sionna Therapeutics

RA Capital Management
Tpg Gp A
OrbiMed Advisors
Viking Global Investors
Atlas Venture Life Science Advisors
Enavate Sciences GP
Jennison Associates
BlackRock
Citadel Advisors
Vanguard Capital Management
Deerfield Management Company
State Street Corporation
Perceptive Advisors
Eventide Asset Management
Standard Life Aberdeen

View all funds holding Sionna Therapeutics